Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial

Am Rev Respir Dis. 1971 Apr;103(4):461-76. doi: 10.1164/arrd.1971.103.4.461.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Alanine Transaminase / blood
  • Alkaline Phosphatase / blood
  • Aspartate Aminotransferases / blood
  • Bilirubin / blood
  • Clinical Trials as Topic
  • Ethambutol / administration & dosage*
  • Female
  • Hospitalization
  • Humans
  • Isoniazid / administration & dosage*
  • Leukocyte Count
  • Liver Function Tests
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis / drug effects
  • Pain / chemically induced
  • Rifampin / administration & dosage*
  • Rifampin / adverse effects
  • Streptomycin / administration & dosage*
  • Tuberculosis, Pulmonary / drug therapy*
  • United States
  • United States Public Health Service
  • Vertigo / chemically induced

Substances

  • Ethambutol
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Alkaline Phosphatase
  • Bilirubin
  • Isoniazid
  • Rifampin
  • Streptomycin